A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, beginning with the first three therapies. . . . → Read More: First Therapies Selected for Multi-Drug ALS Trial
|
|||||
|
|
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M 
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles 
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds 
A drug candidate designed to compensate for damage to brain cells from toxic proteins prevented nerve cell damage and memory loss in lab mice. . . . → Read More: Experimental Drug Shown to Prevent Memory Loss 
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition. . . . → Read More: Response by Patients Shown to Precision Lung Cancer Drug 
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal  Comments are closed  Finance  Asia, biomedical, biotechnology, equity, Europe, investment, Japan, life sciences, medical device, merger, pharmaceuticals, U.K. 
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, university 
The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA. . . . → Read More: Gates Investing in HIV, Tuberculosis Immunotherapies Comments are closed Finance biomedical, biotechnology, equity, Europe, grant, investment, life sciences, pharmaceuticals, preclinical, university 
Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days. . . . → Read More: Deep Learning Techniques Speed Drug Discovery One comment - (Comments are closed) Joint ventures/collaborations, New products Asia, biomedical, biotechnology, Canada, chemistry, China, computer science, engineering, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||